A phase I trial of recombinant human interleukin-1β (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation

M. Elkordy, M. Crump, J. J. Vredenburgh, W. P. Petros, A. Hussein, P. Rubin, M. Ross, C. Gilbert, C. Modlin, B. Meisenberg, D. Coniglio, J. Rabinowitz, M. Laughlin, J. Kurtzberg, W. P. Peters

Research output: Contribution to journal › Article › peer-review